Abaxis
Ortho Clinical Diagnostics, Siemens Healthineers, Roche, and Others Obtain FDA Clearances in October
The FDA granted clearance to Roche for use of its Cobas Cdiff nucleic acid test, which detects the toxin B gene running on the firm's Liat point-of-care instrument.
VANC Acquires HealthTab
HealthTab is a point-of-care platform leveraging Abaxis' Piccolo Xpress analyzer for Canadian pharmacists for cholesterol, triglyceride, and other testing and monitoring.
Abaxis Reports Flat Fiscal Q3 Revenues
The firm's medical business sales were down due to the timing of orders placed by distributors.
Abaxis Reports Flat Preliminary Q3 Revenues
The firm expects revenues to be affected by a difficult comparison to Q3 FY15, currency effects, and reduced orders from distributors.
Point-of-care device manufacturer Abaxis and biosensor firm LamdaGen said this week that they have entered into an R&D agreement aiming to integrate LamdaGen's plasmonic ELISA technology on Abaxis's rotor-based POC platforms.